BiomX
Holding Companies & Conglomerates · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Einstein St Fl 4, Ness Ziona, Central...Phone Number
+972723942377Website
www.biomx.comRevenue
-Stock Symbol
PHGEIndustry
ZI Rank: 4
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
7
4
4
8
4
About BiomX
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.Explore more
BiomX Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BiomX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BiomX has new funding data
Click to see if BiomX had a recent Job posting/layoffs
Check if BiomX has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BiomX recently announced quarterly report
Product Launch: Get notified when BiomX launches new products
BiomX, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if BiomX is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BiomX
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined BiomX as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
BiomX is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
BiomX is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about BiomX.
BiomX financials insights
Gather financial insights about BiomX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$24M
2019
Series B
$32M
2025
Other Financing Round
$12M
2026
Stock/Share Issuance
$3.3M
BiomX Tech Stack
A closer look at the technologies used by BiomX
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Executive Moves, New Hire
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Executive Moves, New Hire
BiomX News & Media
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
Agreement includes an exclusive drone distribution license and an option to acquire a controlling interest in Motomea Agreement includes an exclusive drone distribution license and an option to acquire a controlling interest in MotomeaBiomX And Water.IO Agree To Updated Zorronet Acquisition Terms
Revised agreement provides BiomX with additional flexibility to support Zorronet while further aligning BiomX and Water IO around Zorronet's long-term success Revised agreement provides BiomX with additional flexibility to support Zorronet while further aligning BiomX and Water IO around Zorronet's long-term successBiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
Collaboration expands Zorronet's AI-powered detection, analysis and response capabilities into agricultural security, theft and critical transportation infrastructure protection Collaboration expands Zorronet's AI-powered detection, analysis and response capabilities into agricultural security, theft and critical transportation infrastructure protectionBiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
NETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a company focused on defense, security, and critical infrastructure technologies, today announced that its wholly owned subsidiary Zorronet has completed the transition of its core operations to a new data center.
Read more news
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BiomX
Sign Up For FreeTo access detailed company insights
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis and colorectal cancer. BiomX discovers and validates proprietary bact... Read More
